Engraftment of marrow allografts treated with Campath-1 monoclonal antibodies
- 1 July 1999
- journal article
- clinical trial
- Published by Elsevier in Experimental Hematology
- Vol. 27 (7) , 1210-1218
- https://doi.org/10.1016/s0301-472x(99)00052-1
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- T‐cell‐depleted allogeneic bone marrow transplantation for acute leukaemia using Campath‐1 antibodies and post‐transplant administration of donor's peripheral blood lymphocytes for prevention of relapseBritish Journal of Haematology, 1995
- Long-term follow-up of T-cell depletion for bone marrow transplantationThe Lancet, 1993
- T CELL DEPLETION WITH CAMPATH-1 IN ALLOGENEIC BONE MARROW TRANSPLANTATIONTransplantation, 1988
- EVIDENCE FOR THE INVOLVEMENT OF HOST-DERIVED OKT8-POSITIVE T CELLS IN THE REJECTION OF T-DEPLETED, HLA-IDENTICAL BONE MARROW GRAFTSTransplantation, 1987
- Graft rejection following HLA matched T‐lymphocyte depleted bone marrow transplantationBritish Journal of Haematology, 1986
- Lack of correlation between nucleated bone marrow cell dose, marrow CFU-GM dose or marrow CFU-E dose and the rate of HLA-identical sibling marrow engraftmentBritish Journal of Haematology, 1985
- USE OF ANTI-T-CELL MONOCLONAL ANTIBODY OKT3 TO PREVENT ACUTE GRAFT-VERSUS-HOST DISEASE IN ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR ACUTE LEUKAEMIAThe Lancet, 1982
- Transplantation of allogeneic bone marrow without graft-versus-host disease using total lymphoid irradiation.The Journal of Experimental Medicine, 1978
- Marrow Transplantation for Treatment of Aplastic AnemiaNew England Journal of Medicine, 1977
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958